Blessing W W, Zilm A, Ootsuka Y
Departments of Human Physiology and Medicine, Centre for Neuroscience, School of Medicine, Flinders University, Flinders Medical Centre, Bedford Park, South Australia 5042, Australia.
Neuroscience. 2006 Sep 15;141(4):2067-73. doi: 10.1016/j.neuroscience.2006.05.050. Epub 2006 Jul 11.
Clozapine, an atypical antipsychotic agent important for the treatment of schizophrenia, has marked inhibitory effects on sympathetic outflow to the thermoregulatory cutaneous circulation. In rabbits clozapine reverses ear pinna vasoconstriction induced either by administration of MDMA (3,4-methylenedioxymethamphetamine, ecstasy) or by exposing the animal to a cold environment. In rats, both these procedures are known to increase sympathetic activation of interscapular brown adipose tissue (iBAT) thermogenesis, important for heat production in the rat. In the present study in conscious rats we determined whether clozapine reduces iBAT thermogenesis induced by MDMA and by exposure to cold. We designed our study so that we could also determine effects of clozapine on the acute (stress-induced) increases in iBAT thermogenesis initiated by the process of s.c. injection. MDMA increased iBAT temperature (+1.7+/-0.2 degrees C after 90 min, P<0.01, n=14 measurements from seven rats each studied on two occasions). Clozapine acutely reversed the MDMA-elicited increase in iBAT temperature (-1.3+/-0.2 degrees C 60 min after clozapine treatment following MDMA versus +0.3+/-0.2 degrees C for 60 min after vehicle treatment following MDMA, P<0.01, n=7). Clozapine also reduced stress-induced increases in iBAT temperature, as well as increases elicited by exposing rats to a cold (5 degrees C) environment. Results, taken together with our previous findings, suggest that MDMA activates the sympathetic thermoregulatory outputs (including the output to iBAT) that defend body temperature against cold exposure and that increase body temperature in response to environmental stress. Clozapine's marked inhibition of iBAT thermogenesis may provide a clue to its marked tendency to cause obesity when used to treat humans with mental disorders including schizophrenia. Our demonstration in rats that clozapine decreases sympathetically-mediated increases in iBAT temperature elicited by MDMA adds to the likelihood that clozapine and clozapine-like agents might be therapeutically effective in life threatening hyperthermia induced by MDMA in humans.
氯氮平是一种对治疗精神分裂症很重要的非典型抗精神病药物,对流向体温调节性皮肤循环的交感神经输出具有显著的抑制作用。在兔子身上,氯氮平可逆转由给予摇头丸(3,4-亚甲基二氧甲基苯丙胺,摇头丸)或使动物暴露于寒冷环境所诱导的耳廓血管收缩。在大鼠中,已知这两种操作都会增加肩胛间棕色脂肪组织(iBAT)产热的交感神经激活,这对大鼠产热很重要。在本研究中,我们在清醒的大鼠身上确定氯氮平是否会降低由摇头丸和暴露于寒冷所诱导的iBAT产热。我们设计了我们的研究,以便我们还能确定氯氮平对皮下注射过程引发的iBAT产热急性(应激诱导)增加的影响。摇头丸使iBAT温度升高(90分钟后升高1.7±0.2℃,P<0.01,来自七只大鼠的14次测量,每只大鼠各研究两次)。氯氮平急性逆转了摇头丸引起的iBAT温度升高(摇头丸给药后氯氮平治疗60分钟后为-1.3±0.2℃,而摇头丸给药后载体治疗60分钟后为+0.3±0.2℃,P<0.01,n=7)。氯氮平还降低了应激诱导的iBAT温度升高,以及大鼠暴露于寒冷(5℃)环境所引起的升高。这些结果与我们之前的发现一起表明,摇头丸激活了交感神经体温调节输出(包括对iBAT的输出),这些输出可抵御寒冷暴露并在应对环境应激时升高体温。氯氮平对iBAT产热的显著抑制作用可能为其在用于治疗包括精神分裂症在内的精神障碍患者时明显的致肥胖倾向提供线索。我们在大鼠中的证明表明氯氮平可降低由摇头丸引起的交感神经介导的iBAT温度升高,这增加了氯氮平和类氯氮平药物在人类因摇头丸引起的危及生命的高热中可能具有治疗效果的可能性。